Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

AI Stock Picker
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Resources

Blog
Earnings
Tutorial
Partner Program

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CNTB
    4. >
  4. Valuation

Valuation

-
stocks logo
CNTB
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is CNTB Overvalued？

CNTB is now in the zone, suggesting that CNTB current forward PE ratio of -3.19 is considered compare with the five-year average of -3.89.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

CNTB Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
CNTB.O
Connect Biopharma Holdings Ltd
loss
Average P/E: 0.00
48.08M
stocks logo
KALA.O
KALA BIO Inc
loss
Average P/E: 0.00
43.33%
40.45M
stocks logo
XLO.O
Xilio Therapeutics Inc
loss
Average P/E: 0.00
63.70%
46.56M
stocks logo
ATRA.O
Atara Biotherapeutics Inc
loss
Average P/E: 0.00
-347.35%
40.95M
stocks logo
RNTX.O
Rein Therapeutics, Inc. Common Stock
loss
Average P/E: 0.00
32.91%
58.50M
stocks logo
RGC.O
Regencell Bioscience Holdings Ltd
0.00
Average P/E: 0.00
58.56M

CNTB Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

CNTB FAQs

Is CNTB currently overvalued based on its P/E ratio?

According to the provided data, CNTB's 5-year historical average forward P/E ratio is -3.89. CNTB forward P/E ratio is -3.19, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for CNTB?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for CNTB's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

CNTB PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-3.89
Current PE
-3.19
Overvalued PE
-0.45
Undervalued PE
-7.32

CNTB EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-2.94
Current EV
0.00
Overvalued EV
4.15
Undervalued EV
-10.02

CNTB P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
1.08
Current PS
2.37
Overvalued PS
2.38
Undervalued PS
-0.22

CNTB Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
CNTB.O
Connect Biopharma Holdings Ltd
loss
Average P/E: 0.00
48.08M
stocks logo
KALA.O
KALA BIO Inc
loss
Average P/E: 0.00
43.33%
40.45M
stocks logo
XLO.O
Xilio Therapeutics Inc
loss
Average P/E: 0.00
63.70%
46.56M
stocks logo
ATRA.O
Atara Biotherapeutics Inc
loss
Average P/E: 0.00
-347.35%
40.95M
stocks logo
RNTX.O
Rein Therapeutics, Inc. Common Stock
loss
Average P/E: 0.00
32.91%
58.50M
stocks logo
RGC.O
Regencell Bioscience Holdings Ltd
0.00
Average P/E: 0.00
58.56M

CNTB Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is CNTB undervalued？Is CNTB overvalued compared to its competitors？

CNTB FAQs

Is CNTB currently overvalued based on its P/E ratio?

According to the provided data, CNTB's 5-year historical average forward P/E ratio is -3.89. CNTB forward P/E ratio is -3.19, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for CNTB?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for CNTB's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is CNTB undervalued？Is CNTB overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
AI Stock PickerFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisStock Chart PatternsEarnings TradingAI Screener
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free